Bone mineral density testing, and bisphosphonate and oestrogen prescribing associated with depot medroxyprogesterone acetate utilization-The impact of the boxed warning. [electronic resource]
Producer: 20180126Description: 483-494 p. digitalISSN:- 1365-2710
- Bone Density -- drug effects
- Bone Density Conservation Agents -- administration & dosage
- Contraceptive Agents, Female -- administration & dosage
- Databases, Factual
- Delayed-Action Preparations
- Diphosphonates -- administration & dosage
- Drug Labeling
- Estrogens -- administration & dosage
- Female
- Humans
- Medroxyprogesterone Acetate -- administration & dosage
- Practice Patterns, Physicians' -- statistics & numerical data
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.